Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

NCT06963697 · clinicaltrials.gov ↗

AVAILABLE

Status

OTHER

Sponsor class

Conditions

Cancer

Interventions

BIOLOGICAL: Personalized Synthetic Long Peptide Vaccine

Sponsor

Jaime Leandro Foundation for Therapeutic Cancer Vaccines